Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation TCT 2021

Leading with Evidence: Latest Data on Renal Denervation

Presenter: NULL

November 06, 2021

Presentation TCT 2021

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Presenter: David E. Kandzari

November 04, 2021

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

Presentation TCT 2021

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

Presenter: Ajay Kirtane

November 04, 2021

Presentation TCT 2021

TCT 677: Renal denervation in a young patient with malignant hypertension

Presenter: Maria Antonieta Lopes

November 04, 2021

Presentation TCT 2021

TCT 633: A Clinical Case of Performing Optical CoherenceTomography of the Renal Arteries During Carboxyangiography to Assess the Safety of the Renal Denervation Procedure in a Patient With Uncontrolled Hypertension and Iodine-Containing Contrast Allergy.

Presenter: Mikhail Tarasov

November 04, 2021

News Opinion Editor's Corner TCT 2021

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

Shelley Wood

November 01, 2021

Video

» Interview

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

November 7, 2021

Advertisement

Leading with Evidence: Latest Data on Renal Denervation

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

TCT 677: Renal denervation in a young patient with malignant hypertension

TCT 633: A Clinical Case of Performing Optical CoherenceTomography of the Renal Arteries During Carboxyangiography to Assess the Safety of the Renal Denervation Procedure in a Patient With Uncontrolled Hypertension and Iodine-Containing Contrast Allergy.

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content